Total synthesis of methyl-lysophosphatidic acid and analogues: confirmation of the proposed structure of a phospholipid antigen for CD1c-restricted T cells

14 October 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

CD1c-restricted T cells play a crucial role in immune surveillance and anti-tumor immunity. Recently, a novel methyl-lysophosphatidic acid (mLPA), which bears a rare methyl phosphate headgroup, was identified as a potential antigen for these T cells, selectively accumulating in leukemia cells. However, uncertainties surrounding the structure of this natural product prompted us to pursue its chemical synthesis. Herein, we report the first total synthesis of mLPA, along with its desmethyl and dimethyl analogues. Our synthetic mLPA exhibits spectral characteristics consistent with the reported data for the natural product, confirming the proposed structure and the presence of a mixture of diastereomers. Synthetic mLPA and the two analogues will be valuable tools for investigating the anti-leukemic potential of CD1c-restricted T cell responses.

Keywords

immunity
cancer
antigen
phospholipid
immunotherapy
total synthesis

Supplementary materials

Title
Description
Actions
Title
Supplementary information
Description
1H and 13C NMR spectra
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.